SCHEMBL4391264

SCHEMBL4391264

COC(=O)c1ccc(-c2ccccc2OC(=O)c2ccc(-c3ccccc3O)nc2)nc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.47
KDM4A O75164 1/20 0.46
SLC6A3 Q01959 1/20 0.45
MAPK1 P28482 2/20 0.44
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43
KDM4E B2RXH2 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TGFBR1 P36897 2/20 0.42
KDM1A O60341 1/20 0.42
HDAC1 Q13547 1/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
FAAH O00519 1/20 0.41
PRSS1 P07477 1/20 0.40
ACR P10323 1/20 0.40
FFAR2 O15552 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2071112 0.91 MAPK1 (0.53) KMT2AKDM4AMAPK1RAB9ANPC1
SCHEMBL4391261 0.86 MAPK1 (0.52) KMT2AKDM4AMAPK1RAB9ANPC1
SCHEMBL22353263 0.81 SLC6A3 (0.58) KMT2AKDM4ASLC6A3MAPTMEN1
SCHEMBL1543301 0.81 MAPT (0.41) KMT2AMAPK1RAB9ANPC1KDM4E
SCHEMBL29597637 0.77 MAPK1 (0.54) KMT2AMAPK1RAB9ANPC1KDM4E
SCHEMBL29596848 0.76 MAPK1 (0.51) KMT2ASLC6A3MAPK1RAB9ANPC1
SCHEMBL5934287 0.76 MAPK1 (0.51) KMT2ASLC6A3MAPK1RAB9ANPC1
SCHEMBL1543130 0.75 MAPK1 (0.48) KMT2AMAPK1RAB9ANPC1KDM4E
SCHEMBL2070250 0.75 TGFBR1 (0.49) KMT2AMAPK1RAB9ANPC1KDM4E
SCHEMBL3226202 0.75 KDM4A (0.52) KMT2AKDM4AMAPK1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2129660-A2 NICOTINAMIDE DERIVATIVES AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASES Pfizer Products Inc. (US) 2009-12-09 EP disclosed
WO-2008075172-A2 NICOTINAMIDE DERIVATIVES AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASES PFIZER PRODUCTS INC. (US) 2008-06-26 WO disclosed